Cornerstone Planning Group’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-580
Closed -$789 1262
2024
Q1
$789 Buy
+580
New +$789 ﹤0.01% 831